Aorta MSCTA image optimum contrast agent dosage test method
A test method and contrast dose technology, applied in the field of aortic MSCTA image research, can solve the problems affecting MSCTA image quality, the display rate is not as good as CT, and hazards, so as to reduce the waste of medical resources, reduce the economic burden, and reduce the amount of contrast agent. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] The patient weighs 76kg, uses 80ml of contrast agent, the contrast agent is 370mgI / ml of iopamidol, the injection rate is 5ml / s, the delay time adopts automatic trigger technology, the aorta is significantly enhanced, and the branch vessels are clearly displayed.
Embodiment 2
[0029] The patient weighs 72kg, uses 70ml of contrast agent, the contrast agent is 370mgI / ml of iopamidol, the injection rate is 5ml / s, the delay time adopts automatic trigger technology, and the aorta and branch vessels are clearly displayed.
Embodiment 3
[0031] The patient weighed 75kg, used 60ml of contrast agent, the contrast agent was 370mgI / ml of iopamidol, the injection rate was 5ml / s, and the delay time was automatically triggered. Display is clear.
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com